Perceptions, Representations and Experiences of Septic Isolation of Hospitalized Patients for COVID-19 Infection

COVID19 Clinical Trial

Official title:

Perceptions, Representations and Experiences of Septic Isolation of Hospitalized

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04432922
• Other study ID #: ISOCOV
• Status: Completed
• Start date: November 1, 2020
• Est. completion date: November 15, 2020

Study information

• Verified date: June 2023
• Source: Centre Hospitalier Intercommunal Creteil
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The aim of this study is to analyze the perceptions, representations and experiences of septic isolation of patients hospitalized for COVID-19 infection.

This analysis could lead to better understanding and communication between the medical profession and patients in septic isolation in hospital. It would also provide patient-specific responses to their expectations, as to their families.

Description:

SARS-Cov2 is a new virus responsible for the COVID-19 pandemic. For the first time, it was observed in Wuhan, China in December 2019. For this previously unknown contagious disease, which can cause severe respiratory infections, isolation precautions in hospitals and public places are one of the cornerstones for fighting this pandemic.

Hospital isolation precautions have been present since the 19th century as a means to control the spread of infections. Septic isolation includes contact isolation, droplets and air. Isolation precautions must be prescribed by a physician. To our knowledge, there are few studies about the impact of septic isolation on hospitalized patients at both the psychological level and the relationship with doctors.

This study could enable a better understanding and communication between the medical profession and patients in septic isolation during hospitalization. It could also provide patient-specific responses to their expectations.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 15
• Est. completion date: November 15, 2020
• Est. primary completion date: November 15, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Major patients

• Living in metropolitan France during the SARS-CoV2 pandemic

• Being or having been hospitalized in isolation contact and droplet for a COVID-19 infection (proven or suspected)

• Being in the process of leaving hospital

• Ready for No Opposition for Participation in the Protocol

Exclusion Criteria:

• Patients under guardianship or curatorship

• Patients unable to give free and informed consent;

• Patients under safeguarding justice

• Hospitalized patients on oxygen therapy with speech dyspnea

Related Conditions & MeSH terms

• COVID-19
• COVID19

Intervention

Other:
• Hospitalized Patients for COVID-19 Infection
Face to face semi-directed interviews about perceptions, representations and experiences of septic isolation, including nine opened-questions.

Locations

Country	Name	City	State
France	Centre hospitalier intercommunal de Villeneuve St Georges	Villeneuve St Georges

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Intercommunal Creteil

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	To highlight the perceptions, representations and experiences of septic isolation of patients hospitalized for COVID-19 infection		1 day
Secondary	to identify key elements to improve the medical discourse on septic isolation among patients		1 day